Long-term effectiveness and safety of sirolimus drug-eluting stents
Mahesh Bikkina, Jayanth KoneruSt Joseph Regional Medical Center, Paterson, Seton Hall University, NJ, USAAbstract: The root cause of coronary artery disease is atherosclerosis, ie, intraluminal narrowing (stenosis) of the arteries that supply blood to tissues of the heart. The introduction of the dr...
Saved in:
Main Authors: | Bikkina M, Koneru J |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/5f48c0a8c9a04317ab1e277c88dea198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
by: Jonathan Bridges, et al.
Published: (2008) -
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
by: Brendan Doyle, et al.
Published: (2009) -
Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011) -
Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
by: Panoulas VF, et al.
Published: (2015)